Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: rl who wrote (2077)	2/16/1998 12:37:00 AM
From: Gary Green	Read Replies (4) \| Respond to of 3369

SALV has apparently gone from science to stock manipulation. I am one of the suckers who stayed with this crap too long. No matter what I do now, I will have lost tens of thousands of dollars. I got into this dog when the company touted its FDA application and original clearance in August of 1995. Since that time, I have read dozens of apparently earnest reports from management concerning so called products. I should have realized much sooner than now that if the products were half as good as the company said they were, the world would have beaten a path to its door. Instead, I have seen one shady stock manipulation and financing trick after another. I have witnessed management changes and other tell-tale signs of trouble, and have mourned while I saw my investment shrink to the price of a cheap suit. Today, it would take 5 shares of stock to buy a cup of coffee. I wish the new investors the same bad luck I have had with my foolish investment in this dog. The new investors just kissed $1.5 million good bye. I disagree with rl only to the extent that he thinks the new guys will be able to make money from trading SALV in the future. In my view, hardly anyone wants this stock now, and as each day passes with no operational successes by the company, the stock will attract even fewer buyers. The stock always sold on the basis of its story. Well we investors now know the story was just a tall tale; and the market knows it too. Only a fool would buy into a company that cannot market a device that a significant portion of the public needs. It may be that SALV simply does not have that device, despite its claims to the contrary. ----------------------------------------------------------------- 88888888888888888888888888888888888888888888888888888888888888888888 ---------------------------------------------------------------------- I ask the other posters here to comment on these questions: [1] Does SALV have a product that reliably tests for HIV or AIDS? [2] Why has SALV been unable to sell either its products or the rights (to another company) to manufacture and distribute its products? [3] With R&D completed (as reported in the 10Q) and with little to show that there is any manufacturing, marketing or sales, why is the cash burn so high? [4] Did management lie to us on one or more material issues? I look forward to your views.